Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30819479 | 0.96 | MEN1 (0.31) | MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL10424906 | 0.96 | MEN1 (0.31) | MEN1ALDH1A1TSHRKMT2A | |
| Potassium Ion SCHEMBL30352825 | 0.96 | MEN1 (0.31) | MEN1ALDH1A1TSHRKMT2A | |
| Ammonia Solution, Strong SCHEMBL4377162 | 0.96 | MEN1 (0.31) | MEN1ALDH1A1TSHRKMT2A | |
| Sulfuric Acid SCHEMBL8002259 | 0.92 | — | — | |
| SCHEMBL3081554 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1TSHRKMT2ACA2 | |
| SCHEMBL6545746 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1TSHRKMT2ACA2 | |
| SCHEMBL20580451 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1TSHRKMT2ACA2 | |
| SCHEMBL20580591 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1TSHRKMT2ACA2 | |
| SCHEMBL20580570 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1TSHRKMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152106-B2 | Electrically conducting polyamides | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2024-11-26 | — | — | US | claimed |
| CN-117902712-B | Method for degrading azo dye by using chemical activator to strengthen iron-based amorphous alloy | 中国矿业大学 | 2024-08-20 | — | — | CN | claimed |
| CN-117902712-A | Method for degrading azo dye by using chemical activator to strengthen iron-based amorphous alloy | 中国矿业大学 | 2024-04-19 | — | — | CN | claimed |
| CN-115651448-B | Conductive ink with n-type conductivity and preparation and application thereof | 华南理工大学 | 2024-04-09 | — | — | CN | claimed |
| CN-115651448-A | Conductive ink with n-type conductivity and preparation and application thereof | 华南理工大学 | 2023-01-31 | — | — | CN | claimed |
| EP-3954214-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | Agrivalle Brasil Industria e Comércio de Produtos Agrícolas Ltda (BR) | 2022-02-16 | — | — | EP | claimed |
| US-20210388162-A1 | Electrically Conducting Polyamides | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2021-12-16 | — | — | US | claimed |
| CN-113698690-A | Sustained-release microcapsule film and preparation method thereof | 徐州特之达包装科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| CN-111979566-A | Antenna oscillator surface metallization method | 东莞市正为精密塑胶有限公司 | 2020-11-24 | — | — | CN | claimed |
| WO-2020206518-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | AGRIVALLE BRASIL INDUSTRIA E COMÉRCIO DE PRODUTOS AGRÍCOLAS LTDA (BR) | 2020-10-15 | — | — | WO | claimed |
| WO-2016108972-A1 | MICROBIAL COMPOSITIONS FOR USE IN COMBINATION WITH SOIL INSECTICIDES FOR BENEFITING PLANT GROWTH | FMC CORPORATION (US) | 2016-07-07 | — | — | WO | claimed |
| WO-2016109396-A1 | BACILLUS AMYLOLIQUEFACIENS RTI472 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | FMC CORPORATION (US) | 2016-07-07 | — | — | WO | claimed |
| WO-2016109332-A1 | COMPOSITIONS AND METHODS FOR USE OF INSECTICIDE WITH BACILLUS SP. D747 | FMC CORPORATION (US) | 2016-07-07 | — | — | WO | claimed |
| US-20160183537-A1 | BACILLUS AMYLOLIQUEFACIENS RTI472 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | FMC CORPORATION | 2016-06-30 | — | — | US | claimed |
| US-20160183538-A1 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | FMC CORPORATION | 2016-06-30 | — | — | US | claimed |
| US-20160186273-A1 | BACILLUS AMYLOLIQUEFACIENS RTI301 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | FMC CORPORATION | 2016-06-30 | — | — | US | claimed |
| US-7344913-B1 | Spin on memory cell active layer doped with metal ions | SPANSION LLC (US) | 2008-03-18 | — | — | US | claimed |
| US-6531046-B2 | Seed layer repair method | SHIPLEY COMPANY, L.L.C. | 2003-03-11 | — | — | US | claimed |
| US-20020000382-A1 | Contacting metal seed layer on substrate with acidic electrolyte bath containing acids, copper compounds, suppressors and water, then subjecting to current | SHIPLEY COMPANY, L.L.C. OF MARLBOROUGH (US) | 2002-01-03 | — | — | US | claimed |
| EP-1111096-A2 | Seed layer repair method | Shipley Company LLC (US) | 2001-06-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160186273-A1 | BACILLUS AMYLOLIQUEFACIENS RTI301 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | BTF3, MYB, AGXT | MEN1 3532/4885ALDH1A1 3948/4885TSHR 942/4885 |
| US-20160183537-A1 | BACILLUS AMYLOLIQUEFACIENS RTI472 COMPOSITIONS AND METHODS OF USE FOR BENEFITING PLANT GROWTH AND TREATING PLANT DISEASE | MYB, BTF3, NRDC | MEN1 3107/4885ALDH1A1 4545/4885TSHR 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.